Diabetes mellitus, type 1 Trials in La Rochelle, France
Conditions / Diabetes mellitus, type 1 / La Rochelle, France
Diabetes mellitus, type 1 has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01454284 | A Study in Participants With Type I Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT02098395 | The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT03220425 | Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes. | COMPLETED | PHASE3 |
| NCT02414958 | Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) | COMPLETED | PHASE3 |
| NCT02825251 | Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT00790088 | INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy | COMPLETED | — |
| NCT01520818 | Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes | COMPLETED | PHASE3 |
| NCT00982228 | Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT05628532 | DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial | COMPLETED | NA |
| NCT00095082 | Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes | COMPLETED | PHASE3 |